8 Results for "

EP assay

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "EP assay" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-10835
CAS No.: 861238-35-9
Purity:  99.61%
Research Areas:  

Cardiovascular Disease

DG-041 is a potent, high affinity and selective EP3 receptor antagonist with IC50s of 4.6 nM and 8.1 nM in the binding and FLIPR assay, respectively. DG-041 inhibits PGE2 facilitation of platelet aggregation. DG-041 crosses the blood-brain barrier .
loading...
    loading...
Cat. No.: HY-176293
CAS No.: 1799626-16-6
Research Areas:  

Neurological Disease

EP2 receptor antagonist-3 is a selective EP2 receptor antagonist (IC50: 8 nM in hEP2 SPA assay, 50 nM in hEP2 cAMP assay). EP2 receptor antagonist-3 increases the macrophage-mediated clearance of Amyloid-β plaques. EP2 receptor antagonist-3 can be used for the study of alzheimer’s diseases .
loading...
    loading...
Cat. No.: HY-115487
CAS No.: 1050656-06-8
Purity:  99.69%
Research Areas:  

Inflammation/Immunology Cancer

MF-766 is a highly potent, selective and orally active EP4 antagonist with a Ki of 0.23 nM. MF-766 behaves as a full antagonist with an IC50 of 1.4 nM (shifted to 1.8 nM in the presence of 10% HS) in the functional assay. MF-766 can be used for cancer and inflammation diseases research .
loading...
    loading...
Cat. No.: HY-168878
CAS No.: 3050819-22-9
Target:  

METTL3

Research Areas:  

Cancer

EP652 is a METTL3 inhibitor and antitumor agent with IC50 values of 2 nM, <10 nM, and 37 nM in SPA, intracellular, and ATPlite assays, respectively. EP652 exhibits high selectivity against 40 other methyltransferases and FTO, and possesses favorable pharmacokinetic parameters. EP652 reduces intracellular N 6-methyladenosine (m 6A) levels in mRNA. EP652 inhibits tumor growth and progression of both hematologic malignancies and solid tumors. EP652 can be used for the research of acute myeloid leukemia, ovarian cancer, non-small cell lung cancer, and hypopharyngeal squamous cell carcinoma .
loading...
    loading...
Cat. No.: HY-186253
CAS No.: 3129653-69-3
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

TMEM175 agonist 1 is a TMEM175 agonist, with a human EC50 of 0.378 μM in FLIPR assays and a human EC50 of 0.886 μM in EP analyses. TMEM175 agonist 1 can be used in the research of Parkinson's disease, dementia with Lewy bodies, rapid eye movement sleep behavior disorder, amyotrophic lateral sclerosis, and lysosomal storage diseases .
loading...
    loading...
Cat. No.: HY-186254
CAS No.: 3129652-92-9
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

TMEM175 agonist 2 is a TMEM175 agonist with an EC50 of 0.0446 μM in human FLIPR assays and an EC50 of 0.0453 μM in human TMEM175 EP assays. TMEM175 agonist 2 can be used in research related to Parkinson's disease, dementia with Lewy bodies, rapid eye movement sleep behavior disorder, amyotrophic lateral sclerosis, and lysosomal storage diseases .
loading...
    loading...
Cat. No.: HY-186257
CAS No.: 3129652-66-7
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

TMEM175 agonist 3 (Compound 123) is a TMEM175 agonist, with an EC50 of 0.044 μM in human TMEM175 FLIPR assays and an EC50 of 0.073 μM in human TMEM175 EP assays. TMEM175 agonist 3 can be used in the research of Parkinson's disease, dementia with Lewy bodies, rapid eye movement sleep behavior disorder, amyotrophic lateral sclerosis, and lysosomal storage diseases .
loading...
    loading...
Cat. No.: HY-10835R
CAS No.: 861238-35-9
DG-041 (Standard) is the analytical standard of DG-041 (HY-10835). This product is intended for research and analytical applications. DG-041 is a potent, high affinity and selective EP3 receptor antagonist with IC50s of 4.6 nM and 8.1 nM in the binding and FLIPR assay, respectively. DG-041 inhibits PGE2 facilitation of platelet aggregation. DG-041 crosses the blood-brain barrier .
loading...
    loading...